Y-Intercept (HK)’s Oncolytics Biotech ONCY Stock Holding History

Y-Intercept (HK)’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-13,290	Closed	-$12.6K	–	1957
2026 Q2	$12.6K	Buy	+13,290	New	+$12.3K	﹤0.01%	1646

Other funds holding ONCY

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Cedar Mountain Advisors Lake Oswego, Oregon $590M AUM 11.27% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $218M AUM 37.48% 1-Year Est. Return

Y-Intercept (HK)'s ONCY Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Oncolytics Biotech (ONCY) in Q3 2026, closing a stake of 13,290 shares — an estimated $12.6K sold.

Y-Intercept (HK) first reported a position in ONCY in Q2 2026 and held it in 1 quarter. The position peaked at $12.6K in Q2 2026. 9 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

Y-Intercept (HK) reported no remaining Oncolytics Biotech position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 13,290 Oncolytics Biotech shares in Q3 2026, an estimated $12.6K.
Y-Intercept (HK) first reported a position in Oncolytics Biotech in Q2 2026 and held it in 1 quarter.
Y-Intercept (HK)'s Oncolytics Biotech position peaked at $12.6K in Q2 2026.
9 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.